Page last updated: 2024-10-28

hydroxyurea and Cancer of Salivary Gland

hydroxyurea has been researched along with Cancer of Salivary Gland in 1 studies

Research Excerpts

ExcerptRelevanceReference
"From 09/1991 - 06/2007, 24 high-risk salivary gland cancer patients were treated with surgery, followed by adjuvant chemoradiotherapy for high-risk pathologic features including, perineural involvement, nodal involvement, positive margins, or T3/T4 tumors."1.37Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies. ( Blair, EA; Cohen, EE; Haraf, DJ; Pederson, AW; Portugal, L; Salama, JK; Seiwert, T; Stenson, KM; Villaflor, VM; Vokes, EE; Witt, ME, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pederson, AW1
Salama, JK1
Haraf, DJ1
Witt, ME1
Stenson, KM1
Portugal, L1
Seiwert, T1
Villaflor, VM1
Cohen, EE1
Vokes, EE1
Blair, EA1

Other Studies

1 other study available for hydroxyurea and Cancer of Salivary Gland

ArticleYear
Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies.
    Head & neck oncology, 2011, Jul-26, Volume: 3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Female; Fl

2011